Literature DB >> 9580618

Effects of angiotensin II on intracellular calcium and contracture in metabolically inhibited cardiomyocytes.

D R Boston1, T Koyama, J Rodriguez-Larrain, A Zou, Z Su, W H Barry.   

Abstract

Angiotensin II (A-II) is known to potentiate ischemic dysfunction during ischemia, but the mechanisms involved are not completely established. We examined the effects of A-II on intracellular calcium concentration ([Ca++]i) and cell contracture caused by metabolic inhibition in isolated adult rabbit ventricular myocytes. [Ca++]i was assessed by flow cytometry, using the Ca(++)-sensitive fluorescent probe, fluo-3. After 90 min of exposure to 2 mM cyanide (CN) and 0 glucose, there was a significant increase in myocyte [Ca++]i. This increase was slightly augmented in the presence of 100 nM A-II. In the presence of partial Na+/K+ ATP pump inhibition ([K+]o = 0.8 mM), there was a more significant increase in [Ca++]i associated with exposure to CN + A-II vs. CN alone. Similar results were obtained with CN plus 2-deoxyglucose, and the effect of A-II was inhibited by 10 microM 5-(N-ethyl-N-isopropyl)amiloride. Myocytes exposed to 2 mM CN and 0 glucose gradually developed contracture over a 3-hr period. Addition of 100 nM A-II significantly (P < .01) enhanced loss of rod shape morphology during 3 hr of CN exposure. Partial inhibition of the Na+ pump by exposure to 0.8 mM K+ had no effect on myocyte survival in the absence of CN, but augmented the harmful effect of A-II on cell contracture caused by CN exposure. This effect of A-II was completely reversed by the addition of 1 mM amiloride, a Na+/H+ exchange inhibitor. We conclude that A-II directly enhances cell injury during CN exposure in isolated rabbit ventricular myocytes. We postulate that this effect of A-II is mediated by stimulation of Na+/H+ exchange with resultant increased [Na+]i and subsequent [Ca++]i loading, possibly via reverse Na+/Ca++ exchange.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580618

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins.

Authors:  Yi-Jen Chen; Yao-Chang Chen; Ching-Tai Tai; Hung-I Yeh; Cheng-I Lin; Shih-Ann Chen
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

2.  Ablation of junctin or triadin is associated with increased cardiac injury following ischaemia/reperfusion.

Authors:  Wen-Feng Cai; Tracy Pritchard; Stela Florea; Chi-Kueng Lam; Peidong Han; Xiaoyang Zhou; Qunying Yuan; Stephan E Lehnart; Paul D Allen; Evangelia G Kranias
Journal:  Cardiovasc Res       Date:  2012-03-12       Impact factor: 10.787

3.  The study on intramyocardial calcium overload and apoptosis induced by coxsackievirus B3.

Authors:  X Hu; H Wang; W Lu; Y Dong; P Cheng
Journal:  J Tongji Med Univ       Date:  2001

4.  The Driving Force of the Na/Ca-Exchanger during Metabolic Inhibition.

Authors:  Antonius Baartscheer; Cees A Schumacher; Ruben Coronel; Jan W T Fiolet
Journal:  Front Physiol       Date:  2011-03-11       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.